High prevalence of Epstein-Barr virus type a strain with the 30 b.p. deletion of the latent membrane protein-1 gene in a Japanese population

Pediatrics International

Volumn 41, Issue 5, 1999, Pages 490-495

  Oshima, Miho ^a,c   Azuma, Hiroshi ^b   Okuno, Akimasa ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b JAPANESE RED CROSS SOCIETY   (Japan)

^c NAYORO CITY UNIVERSITY   (Japan)

Author keywords

Dual infection; Epstein Barr virus; Epstein Barr virus subtype; Genotyping; Latent membrane protein 1

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; LATENT MEMBRANE PROTEIN 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; B CELL LYMPHOMA; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE DELETION; HODGKIN DISEASE; HUMAN; INFECTIOUS MONONUCLEOSIS; JAPAN; POINT MUTATION; POPULATION GENETICS; PRIORITY JOURNAL; WISKOTT ALDRICH SYNDROME;

EPSTEIN-BARR VIRUS INFECTIONS; GENE DELETION; GENOTYPE; HERPESVIRUS 4, HUMAN; HUMANS; JAPAN; POINT MUTATION; PREVALENCE; VIRAL MATRIX PROTEINS;

EID: 0032867621     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200x.1999.01122.x     Document Type: Article

References (26)

1. Henle G, Henle W, Diehl V. Relation of Burkitt's tumor-associated Herpes-type virus to infectious mononucleosis. Proc. Natl Acad. Sci. USA 1968; 59: 94-101.
2. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; i: 702-3.
3. Zur Hausen H, Schulte-Holthausen H, Klein G et al. EBV DNA in biopsies of Burkitt's lymphoma and anaplastic carcinoma of the nasopharynx. Nature 1970; 228: 1056-8.
4. Weiss LM, Strickler JG, Warnke RA, Purtilo DT, Klar J. Epstein-Barr viral DNA in tissue of Hodgkin's disease. Am. J. Pathol. 1987; 129:86-91.
5. Wang D, Liebowitz. D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985; 43: 831-40.
6. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor family. Cell 1995; 80: 389-99.
7. Hu LF, Zabarovsky ER, Chen F et al. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J. Gen. Virol. 1991; 72: 2399-409.
8. Chen ML, Tsai CN, Liang CL et al. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992; 7: 2131-40.
9. Knecht H, Bachmann E, Brousset P et al. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993; 82: 2937-42.
10. Sandvej K, Pch SC, Andresen BS, Pallesen G. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated disease: High frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 1994; 84: 4053-60.
11. Chen WG, Chen YY, Bacchi MM, Bacchi CE, Alvarenga M, Weiss LM, Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue: Type A with a high prevalence of deletions within the latent membrane protein gene. Am. J. Pathol. 1996; 148: 17-23.
12. Chang YS, Su IJ, Chung PJ et al. Deletion of an Epstein-Barr virus variant in T-cell lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in Taiwanese population. Int. J. Cancer 1995; 62: 673-7.
13. Khanim F, Yao QY, Niedobitek G, Sihota S, Rickinson AB, Young LS. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 1996; 88: 3491-501.
14. Cheung ST, Lo KW, Leung SF, Chan WY. Prevalence of LMP-1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong. Int. J. Cancer 1996; 66: 711-12 (Letter).
15. Itakura O, Yamada Y, Narita M, Kikuta H. High prevalence of a 30-base pair deletion and single-base mutations within the carboxy terminal end of the LMP-1 oncogene of Epstein-Barr virus in the Japanese population. Oncogene 1996; 13: 1549-53.
16. Kunimoto M, Tamura S, Tabata T, Yoshie O. One-step typing of Epstein-Barr virus by polymerase chain reaction: Predominance of type 1 virus in Japan. J. Gen. Virol. 1992; 73: 455-61.
17. Azuma H, Sakata Y, Sasaki K et al. Hodgkin disease occurring in a patient with extremely high serum antibody titers to Epstein-Barr virus-associated antigens without chronic illness. J. Pediatr. Hematol. Oncol. 1996; 18; 387-91.
18. Azuma H, Sakata H, Saijyo M, Okuno A. Effect of interleukin 2 on intractable Herpes virus infection and chronic eczematoid dermatitis in a patient with Wiskott-Aldrich syndrome. Eur. J. Pediatr. 1993:152:998-1000.
19. Azuma H, Sasaki K, Miyamoto K et al. Atypical Epstein-Barr virus infection during and after intermittent FK506 therapy. Acta Paediatr. Jpn. 1997; 39: 222-5.
20. Knecht H, Bachmann E, Joske DJL et al. Molecular analysis of the LMP (latent membrane protein) oncogene in Hodgkin's disease. Leukemia 1993; 7: 580-5.
21. Wu SJ, Lay JD, Chen CL, Chen JY, Liu MY, Su IJ. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: A comparison with nasopharyngeal carcinoma in an endemic area. J. Med. Virol. 1996; 50: 314-21.
22. Borisch B, Henning I, Laeng, RH, Ernst R, Rainer K, Laissue J. Association of the subtype 2 of Epstein-Barr virus with T cell non-Hodgkin's lymphoma of the midline granuloma type. Blood 1993; 82: 858-64.
23. Klein G. Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 1994; 77: 791-3.
24. Yao QY, Tierney RJ, Croom-Carter D et al. Frequency of multiple Epstein-Barr virus infections in T-cell-immuno-compromised individuals. J. Virol. 1996; 70: 4884-94.
25. Vasef MA, Kamel OW, Chen YY, Medeiros LJ, Weiss LM. Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease. Am. J. Pathol. 1995; 147; 1408-15.
26. Kyaw MT, Hurren L, Evans L et al. Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipients. AIDS Res. 1992; 8: 1869-74.